SummaryIonQ offers a speculative, high-volatility pure-play on quantum computing, with recent positive technology and financial updates supporting long-term value.IONQ's networking and integration capabilities, including the #AQ 64 Tempo system and recent acquisitions, provide a unique competitive advantage in quantum scalability.Despite trading at over 160x forward revenue, fundamentals are secondary; ongoing technological progress and robust liquidity drive the investment thesis.I view IONQ as the best-positioned pure-play quantum name, recommending long-term investors buy on weakness while acknowledging high-risk and fierce competition. Just_Super/iStock via Getty Images
IonQ (IONQ) is one of the several hotly debated quantum computing names in the market, with the stock volatility remaining high. IONQ provides investors with a pure-play opportunity to gain direct exposure to the emerging quantum
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Quick Insights
Recommended For You
2025-12-13 12:244mo ago
2025-12-13 06:534mo ago
Forget Teladoc and Buy This Healthcare Stock Instead
It's time for investors to give up on the telemedicine leader.
Telemedicine leader Teladoc Health (TDOC 0.92%) has been struggling for several years. The company's services are no longer experiencing the kind of demand they did during the pandemic years. Furthermore, some of its otherwise impressive growth drivers, including its virtual therapy service, BetterHelp, are facing stiff competition. The result of all that has been declining revenue.
Management has made some efforts to turn things around, but so far, none have been successful. And in my view, the company is unlikely to bounce back anytime soon. Investors should consider cutting their losses and exploring other beaten-down healthcare stocks -- in particular, Pfizer (PFE +0.25%).
Image source: Getty Images.
Why the drugmaker is a better choice
Pfizer also saw its revenue, earnings, and share price jump significantly during the firs few years of the pandemic. In the pharma giant's case, that was because it marketed one of the leading coronavirus vaccines, Comirnaty, and followed that up by launching Paxlovid, a highly successful antiviral treatment for it. However, the strong sales of those products didn't last long, and over the past three years, Pfizer's revenues have (mostly) declined, and its bottom-line numbers have been uninspiring.
Its shares have declined by 50% over this period. But Pfizer's path to a rebound (unlike Teladoc's) seems clear. Even aside from the fact that Pfizer is a well-established corporation that still generates significant profits, it has made moves in recent years that should pay off in the medium term.
Today's Change
(
0.25
%) $
0.07
Current Price
$
25.86
One of the most important tactics was to splurge on acquisitions, which have allowed it to significantly expand its pipeline. Pfizer is expected to secure approvals for several new products in the next few years, which will help stabilize its sales and earnings growth. The company is also targeting attractive markets such as weight management. It's also pursing new treatments inoncology, which remains one of the largest therapeutic areas in terms of sales, and where there is always a need for breakthroughs.
Pfizer has over 100 programs in clinical trials. Additionally, the drugmaker has initiated initiatives to address potential threats to its stability. For example, Pfizer signed a deal with President Donald Trump that will grant it a three-year exemption from Trump's tariffs in exchange for selling some medicines at lower prices to some groups of patients in the U.S. Pfizer is facing challenges to both its top and bottom lines, but it has a clear path to a better future, which is more than can be said about Teladoc.
Today's Change
(
-0.92
%) $
-0.07
Current Price
$
7.55
Teladoc isn't a cheap stock
Teladoc's ecosystem of members and its international expansion efforts might suggest to some that it has significantly more upside than Pfizer, which is a much larger company by market cap. However, Teladoc has been unable to establish itself in its most important growth market -- virtual therapy -- and continues to bleed red ink while facing competitors in its niche that have much deeper pockets, including Amazon. The telemedicine specialist isn't a bargain and could ultimately destroy more shareholder value in the next few years. Pfizer is a much better option right now.
Wendel (WNDLF) Analyst/Investor Day December 12, 2025 8:30 AM EST
Company Participants
Olivier Allot - Director of Financial Communication & Data Intelligence and Investor Relations
Laurent Mignon - Group CEO & Chairman of the Executive Board
David Darmon - Deputy CEO & Member of Executive Board
Cyril Marie - Executive Vice-President Strategy and Corporate Development
Conference Call Participants
William Rozé
David Cerdan - Kepler Cheuvreux, Research Division
Arnaud Palliez - CIC Market Solutions (ESN), Research Division
Nicolas Tabor
Andee Harris - Crisis Prevention Institute, Inc.
Andrew Lowe - Citigroup Inc., Research Division
Daniel Benin - Committed Advisors SAS
Zia Uddin - Monroe Capital LLC
Geoffroy Michalet - ODDO BHF Corporate & Markets, Research Division
Arnaud Palliez - CIC Market Solutions, Research Division
Saima Hussain - AlphaValue SA
Alexandre Gérard - CIC Market Solutions (ESN), Research Division
Loco Atitaud Lionel Boni Douza - Joh. Berenberg, Gossler & Co. KG, Research Division
Conversation
Olivier Allot
Director of Financial Communication & Data Intelligence and Investor Relations
Welcome to Wendel 24th Investor Day. As you can see, we have quite a nice agenda today, and we hope that these sessions will give you a better understanding of Wendel's new value creation profile. There will be Q&A sessions at the end of each presentation for Wendel, the Q&A session will take place at the very end of this event. For those who are not in the room, you can ask questions from the web, and I will read them.
Given today's very rich agenda, I think it's time to start now with the first presentation by Laurent Mignon, Wendel's CEO. Jingle please.
Laurent Mignon
Group CEO & Chairman of the Executive Board
Good afternoon to everybody. Very happy to be here with you and to share with you the transformation of Wendel and where we want to take Wendel. You'll see that we're pretty passionate about it. I think the team has
Recommended For You
2025-12-13 12:244mo ago
2025-12-13 07:074mo ago
ITGR FRAUD UPDATE: Important Integer Holdings Corporation Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before February 9
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:124mo ago
Meridianbet Partners with BETER to Deploy Fast-Betting Content Across Global Markets
VALLETTA, Malta and LAS VEGAS, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Meridianbet, a leading sports betting and gaming operator and subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has signed a content distribution agreement with BETER, an award-winning provider of fast-betting content, data, and odds for esports and sports.
The partnership integrates BETER's exclusive ESportsBattle series and Setka Cup table tennis tournaments into Meridianbet's sportsbook platform across 18 licensed jurisdictions in Europe, Africa, and South America, including Serbia, Bosnia and Herzegovina, Montenegro, Peru, and additional markets where Meridianbet operates retail and online betting operations.
BETER delivers 24/7 live streaming, real-time data, and odds for approximately 700,000 fast-paced events annually, offering up to 50 markets per event with operator margins averaging 7.5%+. The content provider's portfolio includes esports tournaments (eFootball, eBasketball, eHockey, eTennis) and sports content (Setka Cup table tennis, BSKT Cup basketball, GTR Cup tennis, padel, and cricket coverage).
Deploying 700,000 Annual Events Across Multi-Channel Operations
Fast-betting content represents a growing segment of sports wagering activity, characterized by high-frequency events with sub-15-minute durations that generate elevated player engagement and session frequency. By integrating BETER's exclusive tournament content, Meridianbet expands its betting product portfolio beyond traditional sports offerings, addressing player demand for rapid-action wagering experiences.
Exclusive Content Integration
The content integration supports Meridianbet's omni-channel distribution strategy, with BETER's tournaments available across the operator's retail locations, desktop platforms, and mobile applications in markets spanning three continents. This multi-channel deployment allows Meridianbet to leverage the same content library across different player touchpoints, creating operational efficiencies while expanding betting product variety.
BETER's exclusive tournament model—where the provider controls event production, streaming, and data delivery—provides Meridianbet with differentiated content unavailable from competitors operating solely with third-party sports data feeds. This exclusivity creates product differentiation in competitive markets where licensed operators compete for player acquisition and retention.
Meridianbet's 18-jurisdiction footprint—spanning established European markets (Serbia, Bosnia and Herzegovina, Montenegro) and growing Latin American territories (Peru)—positions the company to leverage content partnerships across diverse player demographics and regulatory environments. By deploying BETER's content globally rather than in selective markets, Meridianbet creates operational leverage where single content integrations generate value across multiple jurisdictions.
The fast-betting content category aligns with Meridianbet's focus on building engagement among younger player demographics who prioritize rapid-action betting experiences over traditional pre-match wagering. As Golden Matrix Group scales Meridianbet's operations across existing and new markets, content partnerships that enhance product differentiation support player acquisition and retention objectives.
About Meridianbet
Founded in 2001, Meridianbet Group is a well-established online sports betting and gaming group, licensed and currently operating in 18 jurisdictions across Europe, Africa, and South America. The Meridianbet Group’s successful business model utilizes proprietary technology and scalable systems, allowing it to operate in multiple countries and currencies with an omni-channel approach to markets, including retail, desktop online, and mobile. The Company is part of the Golden Matrix Group (NASDAQ: GMGI). Contact https://x.com/meridianbet_ofc and [email protected].
About Golden Matrix
Golden Matrix Group (NASDAQ: GMGI), based in Las Vegas, is a gaming technology company operating globally through B2B divisions (GMAG, Expanse Studios) that develop and license proprietary platforms, and B2C operations including RKings (UK competitions), Mexplay (Mexico online casino), and Meridianbet—a leading sportsbook licensed in 18 jurisdictions across Europe, Africa, and South America. Learn more at www.goldenmatrix.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6b879faf-e7d4-43c0-a36c-53bde7d91beb
Meridianbet x Beter
Meridianbet x Beter
2025-12-13 12:244mo ago
2025-12-13 07:134mo ago
FCX FRAUD UPDATE: Important Freeport-McMoRan Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 12
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:164mo ago
INSP FRAUD UPDATE: Important Inspire Medical Systems, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 5
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:184mo ago
SNPS FRAUD UPDATE: Important Synopsys, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 30
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:184mo ago
ARE FRAUD UPDATE: Important Alexandria Real Estate Equities, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 26
Important Alexandria Real Estate Equities, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 26
2025-12-13 12:244mo ago
2025-12-13 07:184mo ago
JHX FRAUD UPDATE: Important James Hardie Industries Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 23
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:184mo ago
MLTX FRAUD UPDATE: Important MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 15
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:184mo ago
LRN FRAUD UPDATE: Important Stride, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 12
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.
2025-12-13 12:244mo ago
2025-12-13 07:214mo ago
KMX FRAUD UPDATE: Important CarMax, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 2
NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.
2025-12-13 11:244mo ago
2025-12-13 04:314mo ago
Ferrovial joins the Nasdaq-100 Index®, achieving new milestone in global growth
Inclusion showcases a strong U.S. market presence and commitment to long-term shareholder value
, /PRNewswire/ -- Ferrovial, a leading global infrastructure company, today announced its inclusion in the Nasdaq-100 Index®, marking a significant milestone in its global growth strategy. This achievement comes one and a half years after the company's initial listing on the U.S. stock market.
"Ferrovial's inclusion in the Nasdaq-100 highlights the strength of our distinctive integrated business model in delivering essential infrastructure. This milestone enhances our visibility with U.S. and global investors, broadens our shareholder base, and reflects market confidence in our ability to develop high-value projects that drive economic growth and help the communities where we operate thrive. We are committed to executing our growth strategy, investing in the U.S. and creating long-term value for our shareholders," said Ferrovial CEO Ignacio Madridejos.
Ferrovial's addition to the index will become effective prior to market open on Monday, December 22, 2025. The company began trading on the U.S. stock market in May 2024, alongside listings in Spain and the Netherlands. This made Ferrovial the first IBEX 35 index component to trade its ordinary shares on Nasdaq.
Ferrovial is one of the largest listed infrastructure companies in North America, where it has operated for more than 20 years building and managing express lanes in Texas, North Carolina, Virginia and Ontario. Currently, the company is also developing the New Terminal One at New York's JFK International Airport.
About Ferrovial
Ferrovial is one of the world's leading infrastructure companies, with a distinctive integrated business model supporting the entire lifecycle of a project from design, financing and construction to operation and maintenance. The company has a global presence and employs over 25,500 people worldwide. North America is the company's growth engine, representing the majority of its asset value, based on analysts' consensus valuation. Ferrovial is triple listed on the U.S, Spanish and Dutch stock markets. It is included in globally recognized sustainability indices such as the Dow Jones Best in Class Index (former Dow Jones Sustainability Index) and strives to conduct its operations in compliance with the principles of the UN Global Compact, which the Company adopted in 2002.
SOURCE Ferrovial
2025-12-13 11:244mo ago
2025-12-13 05:004mo ago
Prediction: This Company Could Rebound 40% in 2026
See why this company could be setting up for a long-term rebound as it pivots into the booming AI power market.
Navitas (NVTS 6.43%) is repositioning itself for long-term growth by exiting low-margin segments and focusing on AI data centers, advanced computing, and high-power electrification. With Nvidia selecting its GaN and SiC power chips and new distribution strength in Asia, the company could be approaching a meaningful turning point that investors should not overlook.
*Stock prices used were the market prices of Dec. 1, 2025. The video was published on Dec. 9, 2025.
Rick Orford has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
2025-12-13 11:244mo ago
2025-12-13 05:004mo ago
Prediction: These 2 Unstoppable Stocks Will Join Nvidia, Apple, Alphabet, and Microsoft in the $3 Trillion Club by 2027
These industry leaders each have a mathematically clear path to join the exclusive $3 trillion club.
Much of what drives the U.S. economy has changed over the past couple of decades. For example, energy stalwart ExxonMobil and industrial bellwether General Electric were the two largest publicly traded companies by market cap in 2005, valued at $375 billion and $362 billion, respectively. Fast forward 20 years, and technology companies -- particularly those well-versed in artificial intelligence (AI) -- lead the list. In fact, nine of the world's 10 most valuable companies have clear ties to AI.
Only four companies have earned membership in the ultra-exclusive $3 trillion club, and each is a powerhouse in its own right. Chipmaker Nvidia tops the charts at $4.5 trillion (as of this writing), with iPhone maker Apple nipping at its heels at $4.1 trillion. Search pioneer Alphabet recently vaulted to No. 3 at $3.8 trillion, while cloud and software provider Microsoft clocks in at $3.6 trillion to take the No. 4 position.
The next generation of triple trillionaires is already in the making. I predict that Broadcom (AVGO 11.43%), at $1.9 trillion, and Meta Platforms (META 1.34%), at $1.6 trillion, will soon make the grade, joining the $3 trillion club by the end of 2027.
Image source: Getty Images.
The case for Broadcom
The accelerating adoption of AI over the past few years has sparked a rapid and ongoing expansion in the data center space. While Broadcom is primarily known as a semiconductor company, many of its networking supplies and accessories are critical components required for the data center buildout.
Furthermore, its Application-Specific Integrated Circuits (ASICs) -- chips that can be customized for specific use cases -- have been hailed as an energy-efficient alternative to Nvidia's graphics processing units (GPUs) for certain large-scale applications.
In the third quarter, Broadcom delivered revenue of $15.9 billion, up 22% year over year, driving adjusted earnings per share (EPS) up 36% to $1.69. Perhaps as importantly, its backlog hit a record $110 billion, fueled by strong demand for AI.
Broadcom has a market cap of $1.89 trillion (as of this writing), so it will take gains of 59% to bring its market cap to $3 trillion. The company is expected to generate revenue of $63.4 billion in 2025, according to Wall Street, resulting in a forward price-to-sales (P/S) ratio of roughly 30. If its P/S remains constant, Broadcom will need to generate revenue of roughly $100 billion annually to support a $3 trillion market cap.
Wall Street is bullish, forecasting revenue growth of 29% annually over the coming five years. If the company meets that benchmark, it could generate $100 billion in revenue and achieve a $3 trillion market cap as early as 2027. Furthermore, it boasts a price/earnings-to-growth (PEG) ratio of 0.42, when any number lower than 1 is the measure of an undervalued stock.
The case for Meta Platforms
Meta Platforms has long been at the forefront of AI development, using these sophisticated algorithms to surface more relevant content on its social media platforms and better target its advertising to the right audience. The advent of generative AI has supercharged the company's results as Meta's Llama AI models are ranked among the best in the industry.
In the third quarter, CEO Mark Zuckerberg revealed that the company's AI recommendation engine was "delivering higher quality and more relevant content." As a result, users are spending 5% more time on Facebook and 10% more on Threads. Higher engagement is boosting advertising revenue, as the average price per ad has increased by 10%.
This success is fueling the company's financial results. In the third quarter, Meta generated revenue of $51.2 billion, which jumped 26% year over year, resulting in adjusted EPS of $7.25, which climbed 20%.
Meta has a market cap of roughly $1.68 trillion (as of this writing), so it will take a stock price increase of roughly 78% to propel its value to $3 trillion. Wall Street estimates that Meta will generate revenue of more than $199 billion in 2025, resulting in a forward price-to-sales (P/S) ratio of 8. Assuming its P/S remains constant, Meta will need to generate revenue of roughly $355 billion annually to support a $3 trillion market cap.
Wall Street is currently forecasting Meta's revenue growth at nearly 15% annually over the next five years. If the company can achieve that benchmark, it could surpass a $3 trillion market cap as soon as 2029.
However, recent reports suggest Meta plans to make steep cuts to its metaverse spending, something that has long weighed on the stock. I suspect investors will reward Meta with a higher multiple, and the resulting valuation expansion will knock a couple of years off those calculations. And a 29 times earnings, the price is right.
Danny Vena, CPA has positions in Alphabet, Apple, Broadcom, Meta Platforms, Microsoft, and Nvidia. The Motley Fool has positions in and recommends Alphabet, Apple, Meta Platforms, Microsoft, and Nvidia. The Motley Fool recommends Broadcom and GE Aerospace and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2025-12-13 11:244mo ago
2025-12-13 05:054mo ago
Should Dividend Stock Investors Buy Visa Stock Before 2026?
Visa could be an attractive choice despite the relatively low dividend yield.
Visa (V +0.63%) is one of the most profitable companies in the world when measured by the operating profit margin.
*Stock prices used were the afternoon prices of Dec. 10, 2025. The video was published on Dec. 12, 2025.
Parkev Tatevosian, CFA has positions in Visa. The Motley Fool has positions in and recommends Visa. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
2025-12-13 11:244mo ago
2025-12-13 05:154mo ago
Massive News for Nvidia: A NeurIPS Reveal Could Accelerate the Next Wave of AI
Learn what NeurIPS means for investors, why Blackwell could drive the next leg higher, and the underappreciated risks.
Nvidia (NVDA 3.30%) is pushing open AI at NeurIPS and showing why Blackwell is becoming the platform that makes frontier mixture-of-experts models practical, faster, and cheaper to run at scale. But China uncertainty and AI bubble fears are real, and when expectations are this high, the next catalyst can move the stock in either direction.
*Stock prices used were the market prices of Dec. 5, 2025. The video was published on Dec. 9, 2025.
Rick Orford has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
2025-12-13 11:244mo ago
2025-12-13 05:154mo ago
The Best Warren Buffett Stock to Buy With $1,000 Right Now
Warren Buffett is a longtime holder of this high-yield stock, collecting its dependable and growing dividend year after year.
Although Warren Buffett has never explicitly spelled out his investment approach, he has provided a summary of it. Essentially, Buffett's approach is to buy well-run companies while they are attractively priced, and then hold for the long term. That's what he did with the high-yield stock featured below, and you can do so too, now that it appears attractively priced again.
Which Buffett stock should you buy?
Buffett owns a portfolio of stocks within Berkshire Hathaway (BRK.A +0.85%)(BRK.B +0.74%), his primary trading vehicle. One of the most attractive right now is integrated energy giant Chevron (CVX 0.48%). It is a stock that Buffett has owned for many years, but given the laggard performance of the energy sector of late, Chevron again looks like an attractive purchase. In fact, Chevron has even been lagging behind the broader energy sector.
Image source: The Motley Fool.
The end result is that Chevron's 4.5% dividend yield is near the high end of the stock's historical yield range. That suggests that Chevron's stock price is attractive right now.
To be fair, the yield has been higher in the past, but the yield peaks tend to be during deep energy price downturns. While it would clearly be more opportunistic to buy when Chevron is deeply unloved, it is very hard to time such industrywide events (and even more difficult to take a contrarian stance and buy when they come along).
Buying Chevron today offers you an attractive entry point to make a small investment, say $1,000. And you are buying one of the best-run energy companies in the world. If the stock drops further from here, you have your foot in the door, and it will be easier from an emotional standpoint to buy more.
What you are buying when you buy Chevron
Chevron is what's known as an integrated energy company. That means the business has exposure to the entire energy value chain, including the upstream (energy production), midstream (pipelines and other transportation assets), and downstream (chemical and refining). Each segment performs slightly differently throughout the energy cycle, which helps to smooth out Chevron's performance over time.
The portfolio is also geographically diverse. Chevron is based in the United States, but it has assets worldwide. This, along with its diversified exposure within the industry, allows the company to make capital investments where management believes they will provide the best returns.
Today's Change
(
-0.48
%) $
-0.73
Current Price
$
149.99
Chevron also has one of the strongest balance sheets among its peer group. The debt-to-equity ratio is currently around 0.22x, which would be low for any company. For Chevron, however, it gives management the flexibility to add leverage during industry downturns so the company can both support its business and its dividend despite weak oil and gas prices.
One of the biggest reasons why dividend investors will appreciate Chevron, however, is its consistent dividend growth. The dividend has been increased annually for 38 consecutive years. Given the inherent volatility of the energy sector, that's an incredible dividend streak. Add that streak to the yield and attractive business model, and it should be hard to say no to this Warren Buffett stock.
You should have some energy exposure
The primary objection to Chevron is likely to be the volatility of the energy sector. That's entirely reasonable; however, Chevron is one of the safest ways to invest in the sector. The key for investors is to keep in mind that energy is vital to the world, and as such, it is advisable to have some exposure to it in your portfolio.
If you do decide to add some energy exposure, Chevron, a longtime Buffett holding, is a very attractive way for dividend investors to round out their portfolios right now. With a commitment of $1,000, you can start your energy toehold with roughly six shares of Chevron.
2025-12-13 11:244mo ago
2025-12-13 05:154mo ago
Is QQQ or VUG the Better Growth ETF? Here's What Investors Need to Know.
QQQ carries a higher expense ratio than VUG and has delivered a slightly stronger 5-year total return. Both ETFs are extremely liquid, with QQQ showing a somewhat lower volatility profile and similar tech-heavy sector allocations.
2025-12-13 11:244mo ago
2025-12-13 05:304mo ago
Apple stock seen entering ‘AI revolution' in 2026: here's what it may look like
Apple Inc. (NASDAQ: AAPL) faces frequent criticism for lagging in artificial intelligence innovation compared to aggressive moves by Microsoft, Google, and Meta. However, 2026 will finally mark the giant's entry into an “AI revolution”, argues Wedbush's senior analyst, Dan Ives.
2025-12-13 11:244mo ago
2025-12-13 05:304mo ago
Warren Buffett's Biggest Artificial Intelligence Bets in 2026: 23% of Berkshire Hathaway's $311 Billion Stock Portfolio Is in These 2 AI Stocks
The once tech-adverse investor has indirectly put a substantial amount of capital into the technology of the moment.
The leader of Berkshire Hathaway, Warren Buffett, was a tech stock holdout for decades. Nothing lasts forever, though, and largely thanks to his lieutenants Ted Wechsler and Todd Combs, Berkshire is now a major institutional investor in such equities.
As such, it's also indirectly at the front of the artificial intelligence (AI) revolution. In fact, nearly one-quarter of Berkshire's equity portfolio market cap is invested in two companies actively utilizing the technology -- Apple (AAPL +0.09%) and Google's parent company, Alphabet (GOOG 1.01%)(GOOGL 1.00%), in the form of its Class A shares. Let's explore how AI is affecting their businesses.
1. Apple
For a huge tech company with considerable resources, Apple hasn't effectively leveraged those advantages to establish any kind of AI leadership. Some might have thought the company would be a pacesetter when it announced Apple Intelligence, its suite of AI-enhanced features, with its usual fanfare in mid-2024.
Image source: Getty Images.
Instead, the rollout of Apple Intelligence (AI, get it?) has felt somewhat haphazard; in some respects, it feels like this historically adventurous company is being cautious at best.
The system is limited to newer products equipped with its more-powerful processors, like the iPhone 17. It also enhances a select group of apps, and in doing so, it basically runs in the background.
To me, the company hasn't yet developed a single whiz-bang piece of software that features AI front and center. That includes Siri, its digital assistant, which has been promised a big AI makeover.
Today's Change
(
0.09
%) $
0.25
Current Price
$
278.28
Apple is a famously secretive company, making it something of a challenge to uncover the core reasons behind its relatively slow development of AI. Turnover might be a factor -- the company's senior vice president of machine learning and AI strategy, John Giannandrea, is departing early next year.
If I had to hazard a guess, I'd say that the company's AI lag might have more to do with corporate culture: It prefers to develop its systems and hardware in-house, partnering only selectively. It also likes its iOS ecosystem to be as smooth, reliable, and stable as possible, and many of the current AI models on the scene are often anything but.
So I wouldn't personally flag Apple as an AI play. In fact, I'm glad the company continues to operate in its wheelhouse of cool devices and the useful services that make them compelling products (and help to juice growth, by the way). I'm holding on to my Apple shares, but AI isn't the reason.
2. Alphabet
By contrast, Alphabet has fully embraced AI and is clearly determined to be a leader in the technology. The company has been active in the AI sphere for longer than many might realize -- its modern deep-learning efforts officially began with the formation of the wonderfully named Google Brain project in 2011.
These days, Alphabet is all about integration with its AI offerings, anchored by the foundational Gemini family of models.
Image source: Getty Images.
AI suffuses a raft of company products these days, most notably (and usefully, I'd say) as a solution embedded in the company's near-unavoidable search function. These days, a user input that reads more like a question than a simple query will often be presented with an AI Overview that does a fairly good and accurate job of covering the topic.
The company's AI technology also contributes to many of Google's public-facing software products. A user can effectively apply it as a co-author in a Google Docs document, for example, and harness data from files stored in Google Drive.
Today's Change
(
-1.00
%) $
-3.14
Current Price
$
309.29
And Alphabet is no slouch when it comes to developing cutting-edge AI hardware. It created tensor processing units (TPUs), powerful specialized chips that can handle the heavy computational needs of AI. The company offers access to them as a service via Google Cloud and is now shifting toward offering them directly to large customers.
Alphabet does not break out granular data on how its AI offerings are helping its fundamentals, but we can safely assume they're a significant driver of growth. In its third quarter, the Google Cloud unit -- which houses many AI tools and services for clients -- experienced a 34% year-over-year increase in revenue to more than $15 billion, largely due to strong demand for these offerings.
So we can say that AI is not only an important technology for Alphabet, it's also sharpening the company's already razor-like competitive edge and helping to bring in billions of bucks in revenue. That, to me, makes it an ideal AI play.
2025-12-13 11:244mo ago
2025-12-13 05:304mo ago
QuantumScape's CEO Just Revealed Game-Changing Progress
Discover why QuantumScape's latest breakthrough could reshape the EV battery landscape and what it means for investors.
QuantumScape (QS 7.74%) is nearing a crucial turning point as its QSE5 solid-state battery reaches new real-world testing milestones. With higher energy density, faster charging potential, and major automaker interest, the upside case is gaining strength even as commercialization remains years away.
*Stock prices used were the market prices of Dec. 5, 2025. The video was published on Dec. 10, 2025.
Rick Orford has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
2025-12-13 11:244mo ago
2025-12-13 05:304mo ago
DNOW: Improving Fundamentals Turn This Cheap Stock Into A Buy (Rating Upgrade)
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-13 11:244mo ago
2025-12-13 05:324mo ago
Boeing: 777X Wins Big, Lower 737 MAX Deliveries Are No Surprise
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Increasing competition from the rise of food delivery companies is a risk to Domino's.
Dividend stock investors are curious whether Domino's (DPZ 0.54%) is a good investment.
*Stock prices used were the afternoon prices of Dec. 10, 2025. The video was published on Dec. 12, 2025.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Domino's Pizza. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
This industry disruptor has worked out well for long-term shareholders.
Without a doubt, Uber Technologies (UBER 0.35%) is one of the most disruptive and innovative businesses on the face of the planet. It upended the taxi industry, leveraging data, technology, and the internet to provide a superior use experience. Its success has resulted in a market cap of $185 billion today, a figure achieved in less than two decades.
Has this growth stock been good for investors? Let's take a closer look at Uber's performance over time.
Image source: Getty Images.
Uber is having a tremendous year
Over the last 12 months, shares of Uber have soared 35% (as of Dec. 9), a gain that comes up well ahead of the S&P 500's (^GSPC 1.07%) total return of 14%.
The stock has performed significantly better in the last three years. It skyrocketed 237% during that time, which would have turned a $10,000 starting investment into $33,700.
Over five years, Uber has climbed 68%, underperforming the broader index by a notable margin. This shows investors just how volatile things can be. Uber shares tanked 18% in 2021 and 41% in 2022, as unprofitable tech stocks temporarily fell out of favor amid inflationary pressures and rising interest rates.
Today's Change
(
-0.35
%) $
-0.30
Current Price
$
85.14
Key metrics are strong, but there is long-term uncertainty
In general, though, Uber's stock price is trending in the right direction. And that's because the fundamentals are strong. The company's key metrics have all been robust.
For instance, Uber ended the third quarter with 189 million monthly active users, up 142% compared to the same period exactly five years ago. During that same stretch, gross bookings and revenue increased astronomically. This is clearly a more dominant business today, as it has a ride-hailing presence in 15,000 cities around the world and 9.4 million drivers and couriers on its platform.
What's more, Uber has morphed into a sustainably profitable company. Operating income totaled $1.1 billion in the third quarter, translating to an operating margin of 8.3%. The business reported $2.2 billion in free cash flow.
Uber's best trait is the presence of a network effect, allowing the mobility and delivery segments to get better as the user base grows. This places the company in an advantageous position as a partner of choice of autonomous vehicle enterprises that want to lean on Uber's technical expertise and direct connection with consumers.
However, it's difficult to say how things will shake out. Should Alphabet's Waymo or Tesla's robotaxi service rapidly scale and find adoption on their own, it could present challenges to Uber.
Nonetheless, Uber is an outstanding business. Investors might want to take a closer look.
2025-12-13 11:244mo ago
2025-12-13 05:364mo ago
BITU: Wait For $73,000 Bitcoin (Technical Analysis)
SummaryProShares Ultra Bitcoin ETF is unsuitable for long-term holding due to daily 2x leverage and compounding decay.BITU can deliver strong returns during sustained Bitcoin rallies but amplifies losses and underperforms spot ETFs during choppy or declining markets.I believe Bitcoin has likely seen its cycle top, with further downside risk of up to 30% from current levels.I am waiting for a deeper pullback, ideally near $73,000 BTC with bullish RSI divergence, before considering leveraged long positions through BITU. oonal/iStock via Getty Images
Just two months after seemingly breaking out to a new all-time high of $126,000 per coin, Bitcoin (BTC-USD) has subsequently fallen all the way to $80,500. Following that late-November low, the coin has since rallied 17% after drawing
Analyst’s Disclosure:I/we have a beneficial long position in the shares of BTC-USD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I'm not an investment advisor.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-12-13 11:244mo ago
2025-12-13 05:594mo ago
EEM: Few Investors Will Benefit From This Unknown Cycle That Has Occurred Since 2003
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-13 10:244mo ago
2025-12-13 03:154mo ago
Broadcom's AI Accelerator Business Is Booming, But the Stock Is Falling. Could This Be the Most Underrated AI Play Right Now?
Some investors are selling Broadcom stock in the wake of its blockbuster financial report. That could be a costly mistake.
The dawn of artificial intelligence (AI) in early 2023 has caused a paradigm shift in the technology landscape. The ability of these sophisticated algorithms to create original content -- including text, images, audio, and computer code -- promises to unleash a windfall of profits by increasing worker productivity and automating mundane and time-consuming tasks.
The first wave of AI was characterized by the rapid adoption of graphics processing units (GPUs), which offer the flexibility and computational horsepower for a broad range of AI tasks. Unfortunately, these AI workhorse chips consume a significant amount of power.
Users are now transitioning to the next phase of AI adoption, seeking more energy-efficient alternatives, and Broadcom (AVGO 11.58%) is profiting from this shift. The company's Application-Specific Integrated Circuits (ASICs) can be customized to a specific task, making them more cost-effective for those instances. The increasing adoption was clear in its financial report.
Image source: Getty Images.
For its 2025 fiscal fourth quarter (ended Nov. 2), Broadcom delivered results that surpassed already bullish expectations with ease. The company generated record revenue of $18.01 billion, which increased 28% year over year, driving adjusted earnings per share (EPS) of $1.95, which climbed 37%.
This was well ahead of analysts' consensus estimates, which called for revenue of $17.46 billion and adjusted EPS of $1.87.
Broadcom's momentum continued, as its AI-centric revenue soared 74% year over year, marking the 11 successive quarter of accelerating gains. During the earnings call, CEO Hock Tan noted that the demand for the company's AI accelerators, AI switches, and other data center products was unprecedented. "We have never seen bookings of the nature [like] what we have seen over the past three months." He also revealed that, in addition to its $10 billion order last quarter, AI start-up Anthropic added an additional $11 billion order to be filled in the coming year.
Today's Change
(
-11.58
%) $
-47.05
Current Price
$
359.32
In response to the company's blockbuster earnings, Broadcom sold off, pushed lower by a rash of profit-taking. This is understandable, given the stock's epic run over the past year, notching gains of 125% heading into its financial report. The stock fell as much as 12% in the wake of Broadcom's report, but Wall Street took a different view.
A whopping 15 analysts raised their price targets on the stock, with several of these bullish calls exceeding $500 per share. The general consensus was that Broadcom's beat-and-raise quarter was evidence of the company's ongoing momentum and it remains a buy. In fact, 96% of the analysts who offered an opinion rate Broadcom a buy or strong buy and none recommends selling.
HSBC analyst Frank Lee maintains a Street-high $535 price target, which represents potential upside of 47% compared to Broadcom's price midday on Friday. The analyst said investors fail to appreciate the increasing potential for the company's ASICs, which are experiencing expanding data center adoption among hyperscale computer operators.
Furthermore, the stock price swoon presents a compelling opportunity for investors, as its valuation has suddenly become much more appealing. Broadcom is currently selling for 28 times next year's expected earnings, and its price/earnings-to-growth (PEG) ratio -- which takes into account its accelerating growth -- comes in at 0.39, when any number less than 1 is the standard for an undervalued stock.
2025-12-13 10:244mo ago
2025-12-13 03:344mo ago
FirstEnergy: Making Good Progress While Putting Bribery Scandal Behind It
SummaryFirstEnergy is initiated at a BUY, as balance sheet improvements and a new CEO suggest the worst is behind the company.FE offers a 4.0% dividend yield, trades at a valuation discount to XLU, and targets 6-8% EPS CAGR with an estimated 5-6% dividend growth rate.AI data-center demand and increased capital deployment are driving a robust growth outlook, with 2025 revenue expected to rise 5-5.5%.Regulatory risks in Ohio remain, but already low TTM ROE in Ohio suggests limited further downside; debt reduction enhances financial flexibility. imaginima/iStock via Getty Images
Five years ago, shareholders in utility company FirstEnergy (FE) were rocked by a rogue CEO swept up in a bribery scandal in the state of Ohio that resulted in an order to pay $250
Analyst’s Disclosure:I/we have a beneficial long position in the shares of XLU either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I am an electronics engineer, not a CFA. The information and data presented in this article were obtained from company documents and/or sources believed to be reliable, but have not been independently verified. Therefore, the author cannot guarantee their accuracy. Please do your own research and contact a qualified investment advisor. I am not responsible for the investment decisions you make.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Quick Insights
Recommended For You
2025-12-13 10:244mo ago
2025-12-13 03:374mo ago
Costco Q1 Earnings: Nice Double Beat But Not Enough Growth
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-13 10:244mo ago
2025-12-13 03:404mo ago
2 Magnificent Stocks to Buy Before They Soar 95% and 215% in 2026, According to Wall Street Analysts
These Wall Street analysts are forecasting substantial gains for shareholders of Nvidia and Circle Internet Group.
Nvidia (NVDA 3.27%) and Circle Internet Group (CRCL 5.76%) have outpaced the S&P 500 (^GSPC 1.07%) year to date, and the following Wall Street analysts are predicting substantial gains in the next year:
Mark Lipacis at Evercore has set Nvidia with a target price of $352 per share. That implies 95% upside from its current share price of $180.
Jeff Cantwell at Seaport Research has set Circle with a target price of $280 per share. That implies 215% upside from its current share price of $89.
Here's what investors should know about these magnificent stocks.
Image source: Getty Images.
Nvidia: 95% implied upside
Nvidia specializes in accelerated computing. Its data center graphics processing units (GPUs) and networking equipment are the industry standard in artificial intelligence (AI) infrastructure. Not only do Nvidia systems regularly outperform products from competing chipmakers when benchmarked across tasks like training and inference, but also its hardware is supported by an unparalleled suite of software development tools called CUDA.
Naysayers often point to growing demand for custom AI accelerators as a significant threat to Nvidia. While several hyperscale companies have developed custom chips, adoption can be difficult because those chips lack pre-built software development ecosystems like CUDA. Consequently, Nvidia systems often have a lower total cost of ownership when adjacent expenses are counted.
Consequently, many industry experts believe Nvidia will retain over 80%-plus market share in AI accelerators for the foreseeable future. Last year, Morgan Stanley analysts wrote:
We have seen many threats to Nvidia come and go since 2018 -- something like a dozen start-ups, several efforts from merchant competitors such as Intel and AMD, and several custom designs. Most of those have come up short. Competing with Nvidia, a company that spends over $10 billion per year in R&D, is a difficult feat.
Importantly, the Trump administration recently said it would approve sales of Nvidia H200 GPUs in China. Previously, export restrictions had effectively locked the company out of China, the second-largest AI market in the world. Analysts are likely to update their forward earnings estimates as the situation continues to develop, and upward revisions could send Nvidia stock higher in the near term.
However, Nvidia is a worthwhile investment whether or not shares pop in the weeks ahead. Grand View Research estimates AI accelerator sales will increase at 29% annually through 2030. That means Nvidia has a long runway for growth despite concerns about an AI bubble. To be clear, I am not ruling out volatility -- Nvidia shares could fall 20% or more -- but I think the stock will continue to beat the S&P 500 as the AI revolution unfolds.
Wall Street expects Nvidia's earnings to increase at 37% annually over the next three years. That makes the current valuation of 44 times earnings look reasonable. I am skeptical about the stock returning 95% in the next year, but the current price is attractive.
Today's Change
(
-5.76
%) $
-5.10
Current Price
$
83.47
Circle Internet Group: 215% implied upside
Circle is a fintech company that mints stablecoins and provides developer services. It is best known for USDC, a stablecoin pegged to the U.S. dollar. USDC is the second-largest stablecoin by market value behind Tether, but it is the largest stablecoin ecosystem that complies with regulatory requirements in the United States and Europe.
Circle primarily earns revenue from interest on reserve assets (i.e., the fiat currency held in reserve to back its stablecoins). However, the company recently expanded into payments with the Circle Payments Network (CPN), which settles transactions almost instantly and addresses use cases like supplier payments, employee payroll, and online shopping.
The stablecoin market is worth $315 billion today. Several analysts think that figure will hit $2 trillion by 2030, implying annual growth of 45%. However, other estimates are even more optimistic. U.S. Treasury Secretary Scott Bessent recently predicted the stablecoin market would hit $3 trillion by 2030, and Bernstein analysts think it will reach $4 trillion by 2035.
Circle should be a big winner. Scale and regulatory compliance have made it the preferred stablecoin among financial institutions. JPMorgan analysts write, "Transparent reserve management and regular audits make it more trustworthy among institutional investors and other regulated entities." The note specifically emphasizes compliance with regulatory frameworks in the U.S. and Europe.
Wall Street estimates Circle's revenue will increase at 32% annually through 2027. That makes the current valuation of 8.2 times sales look fairly attractive. Investors should feel comfortable buying a small position at the current price, though Jeff Cantwell's target (which implies 215% upside) is probably too optimistic.
JPMorgan Chase is an advertising partner of Motley Fool Money. Trevor Jennewine has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Evercore, Intel, JPMorgan Chase, and Nvidia. The Motley Fool has a disclosure policy.
2025-12-13 10:244mo ago
2025-12-13 03:434mo ago
These 3 Warren Buffett AI Stocks Could Be Big Winners in 2026
The "As" have it. Buffett's top AI stocks -- Alphabet, Amazon, and Apple -- should deliver solid gains next year.
Warren Buffett and artificial intelligence (AI) go together like... Well, they don't go together. The legendary investor has readily admitted in the past that he doesn't understand AI.
However, Buffett's Berkshire Hathaway (BRK.A +0.85%) (BRK.B +0.74%) portfolio includes three top AI stocks. And they could all be big winners in 2026.
Image source: The Motley Fool.
1. Alphabet
In 2017, Buffett told CNBC that he regretted not buying shares of Google's parent company, Alphabet (GOOG 1.03%) (GOOGL 1.03%), earlier. He recently remedied that mistake, loading up on the stock in the third quarter of 2025.
Alphabet is on a big-time AI-fueled roll. The stock has skyrocketed almost 70% year-to-date after sinking more than 20% by early April. I predict AI will continue to serve as a significant tailwind for Alphabet in 2026.
Today's Change
(
-1.03
%) $
-3.21
Current Price
$
309.22
Google Cloud will almost certainly remain the company's primary growth driver. The successful launch of Google's Gemini 3.0 large language model (LLM) could make Google Cloud more attractive than ever to companies seeking to harness the power of AI.
Nvidia (NVDA 3.30%) might feel some heat next year from Google, too. Although Nvidia's GPUs are still the gold standard among AI chips, Google's most powerful Tensor Processing Units (TPUs) are garnering increasingly more attention. Meta Platforms (META 1.34%) is reportedly considering a multibillion-dollar deal to use Google's TPUs in its data centers.
Don't overlook the likelihood that Google's advertising profits will continue to rise steadily in 2026, thereby pushing its share price higher. The integration of generative AI through AI Overviews and AI Mode has been a hit, with search traffic increasing as a result.
2. Amazon
Buffett didn't make the initial decision to invest in Amazon (AMZN 1.80%) back in the first quarter of 2019. However, he's no doubt happy with the call now. Amazon's stock is up roughly 160% since the end of Q1 of 2019 – a stronger performance than Berkshire Hathaway.
Amazon hasn't delivered awe-inspiring returns this year. The stock is up by a meager single-digit percentage while the S&P 500 (^GSPC 1.07%) has soared. But I suspect Amazon will fare better in the new year.
Today's Change
(
-1.80
%) $
-4.15
Current Price
$
226.13
The company's underlying businesses remain strong. Amazon CEO Andy Jassy stated in the Q3 update that AI was driving "meaningful improvements in every corner of our business." These improvements were especially evident in Amazon Web Services (AWS), which saw sales jump 20% year-over-year to $33 billion.
Agentic AI could be especially important to AWS' growth in 2026. Jassy noted in Amazon's Q3 earnings call, "A lot of the future value companies will get from AI will be in the form of agents. AWS is heavily investing in this area and well well-positioned to be a leader." I think he's right. And I predict that we'll see the early fruits of the agentic AI investments next year.
3. Apple
It might seem like Buffett has soured on Apple (AAPL +0.04%), considering that he's drastically reduced Berkshire's stake in the consumer technology giant. However, Apple remains the largest holding in Berkshire's portfolio. Buffett's sales of the stock don't appear to reflect a change in his view of the company's business.
Apple's stock performance is lagging behind that of the S&P 500 this year. If you look closely, though, you'll see that Apple has trounced the S&P 500 in recent months. I think that momentum will roll over into 2026.
Today's Change
(
0.04
%) $
0.11
Current Price
$
278.14
The company reported iPhone sales of $49 billion for fiscal 2025 Q4, a record high for a September quarter. Counterpoint Research projects that the iPhone will be the top-selling smartphone in 2025, a spot it hasn't held in 14 years.
My hunch is that another device could be the big story for Apple next year, though. The company is expected to unveil its first smart glasses in late 2026. While the launch of the new product is likely to occur in early 2027, the anticipation of a sales catalyst could be all that's needed to send Apple's share price soaring higher.
Keith Speights has positions in Alphabet, Amazon, Apple, Berkshire Hathaway, and Meta Platforms. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, and Nvidia. The Motley Fool has a disclosure policy.
SummaryFirst Trust NASDAQ Technology Dividend Index Fund ETF is rated a Buy, driven by its structural semis exposure and AI infrastructure tailwinds.TDIV has transformed from defensive tech to a high-growth play, outperforming both S&P 500 and NDX in recent years despite lacking mega-cap tech names.The ETF’s methodology favors large-cap, cash-flow-rich semiconductor companies, benefiting from secular AI-driven demand and robust dividend payouts (~1.3% yield).TDIV is positioned to outperform QQQ and software-focused AI themes over the next 12–18 months, though ongoing monitoring of semis cyclicality is advised. Hiroshi Watanabe/DigitalVision via Getty Images
The First Trust NASDAQ Technology Dividend Index Fund ETF (TDIV) presents a very interesting way to play tech at the moment. When we look at it from various time slices, we see different outcomes. The outperformance
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Investors are extremely optimistic about Tesla's prospects in driverless car technology and robotics.
Tesla (TSLA +2.57%) might be one of the most polarizing stocks in the markets right now.
*Stock prices used were the afternoon prices of Dec. 10, 2025. The video was published on Dec. 12, 2025.
Parkev Tatevosian, CFA has the following options: long December 2026 $320 puts on Tesla. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
These players are well-positioned to potentially gain next year -- and over time.
Overall, the past three years have been positive for investors, with the S&P 500 bull market going strong. The famous benchmark advanced more than 20% in each of the past two years, and today it's heading for yet another double-digit annual gain. Technology stocks have fueled this movement as artificial intelligence (AI) emerged as the next major game changer, and investors also piled into growth stocks across industries on optimism about lower interest rates.
It's impossible to predict with 100% certainty which direction the S&P 500 will take next year, but there's reason to be optimistic about its performance then and over time; history shows us that bull markets usually last much longer than bear markets.
With all of this in mind, let's check out my top 10 stocks to buy for 2026. They offer you a balanced blend of characteristics, from growth and innovation to safety and passive income.
Image source: Getty Images.
1. Nvidia
Let's start with a company that has significantly driven market gains during this AI boom: Nvidia (NVDA 3.27%), the world's leading AI chip designer. This tech giant has seen earnings soar, and this movement may have much farther to go, as this technology is in the early chapters of its story.
Nvidia's positioned to benefit greatly from AI infrastructure spending, which may reach into the trillions of dollars over the next five years. And, over time, AI models will continue to rely on chips to power them through their job of applying AI to real-world problems. All of this suggests many bright days ahead for Nvidia and its shareholders.
2. Eli Lilly
Eli Lilly (LLY +1.80%) already has seen earnings take off thanks to its weight loss drug portfolio. Tirzepatide, sold as Mounjaro for type 2 diabetes and as Zepbound for weight loss, has delivered blockbuster revenue -- and has helped Lilly's total revenue climb in the double-digits.
Today's Change
(
1.80
%) $
18.13
Current Price
$
1027.51
Recently, Lilly delivered solid phase 3 results for its oral weight loss candidate -- orforglipron -- and regulatory review of that candidate is the next step. All of this means orforglipron soon may reach commercialization and boost Lilly's already booming weight loss portfolio.
This makes right now an excellent time to get in on this pharma player that offers you safety and growth.
3. American Express
American Express (AXP 0.60%) is a giant in the payment card market, generally serving high-income customers. Its membership base makes the company a solid investment during any economic environment, because high-income individuals continue spending regardless of the economic situation -- and this has resulted in steady earnings growth for American Express over time.
In recent quarters, American Express has spoken of growth in younger customers -- Millennials and Gen-Z made up 64% of new accounts in the latest quarter. This suggests the payments powerhouse is well-positioned for more growth in the years to come.
Image source: Getty Images.
4. CoreWeave
CoreWeave (CRWV 9.99%) exploded onto the scene this year, climbing more than 300% from its market launch in March through June. The stock has since dropped from that high -- and it now has plenty of room to run.
Today's Change
(
-9.99
%) $
-8.73
Current Price
$
78.65
This company offers AI customers what they need most today, and likely into the future, and that's capacity for workloads. CoreWeave rents out its fleet of high-powered chips, and this could drive the company's already surging revenue higher in 2026 -- and beyond. So, now is a great time to get in on this AI growth player.
5. Viking Therapeutics
Viking Therapeutics (VKTX 0.35%) aims to enter the billion-dollar weight loss drug market, and so far, the company is marching steadily toward that goal. Viking's injectable candidate is involved in phase 3 trials, and its oral candidate is involved in phase 2 -- both have delivered promising results so far.
Though Eli Lilly and Novo Nordisk dominate the market right now, demand is high, suggesting there's room for others to carve out share here. Viking, with candidates that function in the same way as the Lilly and Novo drugs, could emerge as a new winner in this market in a few years -- so it's a wise idea to get in on this story early.
6. Meta Platforms
Meta Platforms (META 1.30%), trading for 26x forward earnings estimates, is the cheapest of the Magnificent Seven tech stocks that have led market gains. That's one reason to buy the stock now.
Today's Change
(
-1.30
%) $
-8.48
Current Price
$
644.23
And I have two more reasons: Meta is a well-established company with earnings growth you can count on, and it also offers you a top AI bet. Meta is committed to investing in AI and using it to supercharge revenue in the years to come. The company already has gotten started, building its own large language model and virtual assistant, for example. But much more should be on the horizon, making this an exciting and cheap growth stock to buy now.
7. Abbott Laboratories
Abbott Laboratories (ABT +1.77%) is a Dividend King, meaning it's raised its dividend payments for more than 50 consecutive years. This shows the company's commitment to dividend growth, and Abbott's strong free cash flow suggests it has what it takes to keep this on track, too.
ABT Free Cash Flow data by YCharts
I also like Abbott because of its diversification across businesses -- medical devices, diagnostics, nutrition, and established pharmaceuticals. This broad range of operations is positive because, if and when one faces headwinds, others may compensate. On top of this, Abbott sells industry-leading products, such as the FreeStyle Libre continuous glucose monitor and Ensure nutrition drinks. All of this makes it a solid healthcare stock to buy and hold.
8. UnitedHealth
UnitedHealth Group (UNH +1.52%), the biggest U.S. health insurer, has faced various headwinds in recent quarters -- including the rising costs of healthcare. But the company has taken note of the issues that have weighed on earnings and is addressing them.
The efforts -- such as cutting certain plans and using AI to gain in efficiency -- already are bearing fruit, with the company recently increasing its guidance for full-year earnings. Meanwhile, the stock, considering UnitedHealth's industry leadership and long-term prospects, looks cheap at 20x forward earnings estimates. So if you're looking for a promising recovery story for 2026, UnitedHealth may be it.
Image source: Getty Images.
9. Chewy
Chewy (CHWY 4.18%) is the best friend of cats, dogs, and goldfish -- and you might take a liking to this company too. That's because this e-commerce player selling pet food, toys, healthcare, and more has a loyal following of customers, and this has led to steady growth.
The key number I always point out is Chewy's AutoShip sales -- this program allows for the automatic reordering of your favorite products according to a schedule you choose. AutoShip sales account for more than 80% of Chewy's net sales, offering us visibility on sales to come. Chewy also is profitable and debt-free, two other reasons to like this consumer goods stock.
10. Amazon
Finally, if you aim to invest in an established market giant that also offers you outstanding growth potential, consider Amazon (AMZN 1.80%). The e-commerce and cloud computing titan has an established track record of growth and billion-dollar profit – but it's not stopping there and instead is set to win in the high-potential area of AI.
Today's Change
(
-1.80
%) $
-4.15
Current Price
$
226.13
AI already has helped Amazon Web Services (AWS) reach a $132 billion annual revenue run rate, and AI has been favoring efficiency across Amazon's e-commerce business. Moving forward, AI could continue to supercharge growth in both of these businesses, making the stock look reasonably priced now at 32x forward earnings estimates.
And that's why Amazon is a top tech stock to buy and hold for 2026 and beyond.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of VIOT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-13 10:244mo ago
2025-12-13 04:124mo ago
Chipotle Mexican Grill: Company-Specific Initiatives Poised To Drive Growth Reacceleration In 2026
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-13 10:244mo ago
2025-12-13 04:134mo ago
AVK: Preserves Investor Capital And Maintains Consistent Dividends (Rating Upgrade)
HomeETFs and Funds AnalysisClosed End Funds Analysis
SummaryAdvent Convertible & Income Fund is upgraded to Buy, offering an 11.1% yield and trading at a 4.61% discount to NAV.AVK’s hybrid strategy, with 48.7% in convertibles and 41% in high-yield securities, targets high income and capital preservation.Leverage remains high at 37.7%, but declining interest rates should reduce risk and improve operating spreads for AVK.Consistent monthly payouts, tax-efficient distributions, and resilience through rate cycles make AVK attractive for income-focused, buy-and-hold investors. PM Images/DigitalVision via Getty Images
Overview As market indexes hover near their all-time highs, it can be scary to accumulate equities at this time. However, there are many attractive opportunities across income funds as valuations remain suppressed due to higher interest rates. Advent
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Lyft delivered solid milestones in 2025, but 2026 will be the real test of the sustainability of its achievements.
Lyft (LYFT 0.80%) enters 2026 in a stronger position than it has seen in years.
After a long period defined by market-share pressure, cash burn, and questions about long-term viability, the company finally delivered consistent profitability, expanded internationally through the Freenow acquisition, and tightened its operations.
But 2026 won't be about declaring victory; it will be about validating the progress Lyft made in 2025. Here are the key things the company needs to prove in the year ahead.
Image source: Getty Images.
Lyft must show that profitability is durable, not cyclical
Lyft's biggest achievement in 2025 was consistency. The company produced multiple quarters of positive free cash flow and expanding EBITDA margins, something that once seemed out of reach.
But ride-hailing remains a thin-margin business, and investors will want proof that Lyft's profitability can withstand competitive and macroeconomic pressures.
In 2026, Lyft needs to demonstrate:
Stable incentive costs despite a competitive labor market.
Healthy driver supply without overspending.
Improved ride density, which boosts margins.
Continued operating leverage as ride volume grows.
The market will pay close attention to whether Lyft can expand margins even modestly. If profitability slips, especially due to higher subsidies or promotions, investor confidence could fade quickly.
Lyft's bull case depends on this point more than any other: Profitability must become a structural feature, not a temporary byproduct of one strong year.
Today's Change
(
-0.80
%) $
-0.17
Current Price
$
20.36
Lyft must integrate Freenow smoothly and turn it into a growth driver
The Freenow acquisition is the most significant strategic move Lyft has made since going public. It gives the company a meaningful presence in Europe and exposure to regulated taxi markets, premium urban riders, and denser mobility ecosystems.
But the real test begins in 2026. Lyft must integrate two different technology stacks, unify payment systems, and align pricing and onboarding processes across markets that operate very differently from North America. Europe's mobility landscape is fragmented, highly regulated, and city-specific. Each region has its own taxi rules, licensing frameworks, and views on surge pricing.
If Lyft handles this complexity well, Freenow can become a multiyear growth engine that diversifies revenue and strengthens Lyft's platform. If integration missteps occur, the acquisition risks become a distraction that weighs on margins and complicates execution.
Investors will look for signs of synergy -- smoother operations, higher utilization, and more consistent contribution -- to validate the deal.
Lyft must defend its competitive position without sacrificing discipline
Lyft managed to stabilize its competitive footing in 2025. Active riders grew, gross bookings improved, and the company held share in key markets despite Uber's scale advantage. The challenge in 2026 is to maintain that momentum without reigniting costly incentive battles or promotional spending.
Uber's breadth remains a structural edge. It operates at a greater scale, runs a more diversified business, and has more flexibility to withstand pricing or regulatory shocks. Lyft's best path forward is focus: operating efficiently, improving service quality, and continuing to refine pricing systems that attract riders without eroding margins.
To show competitive resilience, Lyft must keep riders engaged, maintain strong driver satisfaction, and continue improving ride completion reliability. Any meaningful slip in these areas would raise concerns about Lyft's ability to compete sustainably in a market where scale matters.
What it means for investors
Lyft enters 2026 with genuine momentum, but also a higher bar. The company must prove that profitability is sustainable, that Freenow integrates smoothly, and that it can compete against Uber without losing discipline.
If Lyft executes well, 2026 could be the year its turnaround becomes a durable growth story. If not, the gains of 2025 could fade as quickly as they appeared.
For long-term investors, the company's execution this year will determine whether Lyft becomes a steady compounder or remains an underdog with flashes of potential.
Either way, investors should monitor the stock closely in 2026.
2025-12-13 10:244mo ago
2025-12-13 04:194mo ago
Ilika ships 10Ah battery prototypes on schedule - ICYMI
Ilika PLC CEO Graeme Purdy talked with Proactive about a significant milestone for the company as it successfully shipped its 10Ah Goliath battery prototypes on schedule. Purdy noted that the delivery reflects the company's commitment to meeting expectations and keeping to its timelines.
The prototypes will now be evaluated by customers, with Ilika expecting collaborative feedback to further refine its solid-state battery technology. Purdy explained that the next key milestone is the development of a 50Ah cell and that licensing discussions are already underway. He emphasised Ilika’s asset-light model, saying that the company does not intend to build large factories itself but will rely on technology transfer and partners to scale up.
Ilika’s pilot line has achieved a 93% yield, which Purdy described as a “really great validation that we have a robust process that is ready for scale up.” This result exceeds typical expectations at this stage and supports the transition towards commercialisation.
The interview also touched on Ilika’s modelling work with Balance Batteries Ltd, which demonstrated potential cost and performance benefits for EV applications. The company claims a 20% reduction in battery pack costs and a corresponding increase in vehicle range when using its technology.
Proactive: I'm joined by Graeme Purdy, the CEO of Ilika PLC. Graeme, good to speak with you. A significant milestone as the year draws to a close — you've just shipped the 10Ah prototypes on schedule, so a big move for you!
Graeme Purdy: Well, absolutely. At Ilika, we pride ourselves in delivering on time and to expectations. The team is absolutely delighted that we've been able to give our customers an early Christmas present.
Proactive: Maybe stronger batteries than they'll need to power the Christmas tree though, Graeme. So what's the next major step to move Goliath towards commercial production or licensing?
Graeme Purdy: We'll be working closely with those customers to evaluate the performance of the cells. It's interesting — in the industry there are a number of different perspectives on the best duty cycles to test batteries with. Although we have done an extensive testing program already, we will be learning alongside customers, and we expect to get some useful feedback that will help us develop even better batteries.
Our next milestone is the 50Ah cell that we're targeting. We're also opening discussions for tech transfer and further scale-up. That is likely to be done by our partners rather than us. It's really important to emphasise that we have an asset-light business model that relies on licensing our technology, rather than Ilika itself building large factories.
Proactive: The pilot line hit a 93% yield. How close is that to commercial requirements, and what does it mean for scaling?
Graeme Purdy: That's a really great question. If you speak to people in the industry, they'll typically say that at a pilot line scale — where Ilika is — you'd expect about 80% yield for it to be considered credible and ready for further scale-up. By the time you get to production, you want a minimum of about 90%. So the fact that we've got 93% on our pilot line is a really great validation that we have a robust process that is ready for scale-up.
Proactive: How do the weight and cost advantages of your oxide coatings strengthen Ilika’s position against established battery markets?
Graeme Purdy: We're all dying for better batteries. We want longer range in our vehicles; we want EVs to cost less. This is the mission that Ilika is on. Irrespective of the fact that this is a solid-state battery development program, we're actually trying to improve batteries so that we, as consumers, have a better experience using them in EVs and other applications.
When we modelled these batteries together with a specialist consultant, Balance Batteries Ltd, and applied that in an EV scenario, we saw a 20% saving on the cost to the pack and also an increase in vehicle range — so that's really important.
Proactive: What's next, Graeme? What should we be watching out for as the year draws to a close and we head into 2026?
Graeme Purdy: We've also got our second product line, Stereax, which is cooking on all gas rings right now as we head into the festive period. So there may well be some additional news associated with that. And then early in the new year, we'll have a bit of a wrap-up with half-year results. I hope we'll get the opportunity to update you again at that point.
2025-12-13 10:244mo ago
2025-12-13 04:194mo ago
Melanoma trial success moves Scancell to phase III - ICYMI
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) CEO Phillip L’Huillier talked with Proactive about new clinical data from its phase two melanoma study, known as the SCOPE trial, featuring its lead ImmunoBody candidate, iSCIB1+.
L’Huillier highlighted that the trial has achieved the objectives set out for it, confirming the parameters for the company’s upcoming registrational phase three study. The findings now provide clarity on dosing, patient population, and trial design. “Our SCOPE study…has met the objectives that we set out for it,” he said.
A key point of the discussion focused on the data, which showed a 74% progression-free survival rate at 16 months for iSCIB1+. This compares to 46% at 12 months for the standard of care, which typically includes dual checkpoint inhibitors Ipilimumab and Nivolumab. L’Huillier noted this as a "really strong and durable benefit" on top of existing treatments.
He also addressed how iSCIB1+ performed across patient subgroups where existing therapies are typically less effective—such as BRAF, PD-L1 status, and those with prior checkpoint treatment, with results showing clinically meaningful benefit across all.
Scancell now plans to begin its phase three trial in late 2026, having received supportive regulatory feedback. L’Huillier also said the data has materially strengthened the company’s case for partnering and financing opportunities as part of a dual-track strategy to either partner or proceed independently.
Proactive: Phil, very good to speak with you. You’ve just released an update on your lead trial in melanoma, which will be the focus of your presentation at ESMO IO on Thursday. Can you summarise the key takeaways, please?
Phillip L’Huillier: I'd like to make three points about our announcement. Firstly, I'm very pleased to say that our SCOPE study — our phase two study testing our lead ImmunoBody agent iSCIB1+ — has met the objectives we set out for it. This exploratory study has enabled us to define the parameters for the next phase, the registrational study.
We now know how to give our therapy, at what dose, and which patient population to take forward. So we've got the parameters defined for the next study.
Secondly — and importantly — it's all about the data. In today’s competitive industry, data is key. Our data is consistently showing good durable benefit in patients. We’re now seeing a 74% progression-free survival at 16 months for iSCIB1+, compared with 46% at 12 months for the standard of care, which is a combination of Ipilimumab and Nivolumab. So, we’re seeing a really strong and durable benefit on top of standard of care.
Additionally, we’re sharing further data showing benefit in patient populations where checkpoint therapies are historically less efficacious — such as those with BRAF mutations, PD-L1 status, and those who’ve had prior checkpoint therapy. iSCIB1+ is showing good, clinically meaningful benefit across these subgroups.
Thirdly, we’re reinforcing the value of HLA type as a predictive marker. We see a clear difference between the target population — which represents 80% of advanced melanoma patients — and the non-target population. We’re also seeing T-cell responses, including memory-like responses, which correlate with clinical benefit. Taken together, we’re seeing immune responses translating into clinical benefit across broad melanoma subtypes.
Proactive: Phil, what does this new update mean for Scancell, practically speaking?
Phillip L’Huillier: Practically, this moves our program from a proof-of-concept study into late-stage development. We now know the parameters for designing our phase three study and have had supportive feedback from regulators. This will help us finalise the design of our registrational study, which we plan to kick off later in 2026.
It’s also materially strengthened our proposition for partnering and refinancing. The maturity of the data supports these conversations.
Proactive: What's next then, Phil?
Phillip L’Huillier: Next is to focus on regulatory conversations to gain full alignment on the phase three study design. In parallel, we’ll accelerate discussions with potential partners and financiers to fund the phase three study. We’re executing a two-pronged strategy — being opportunistic with partnerships, while also ensuring the organisation has the talent, resources, and vendor relationships to go it alone if needed.
Proactive: Phil, I hope you’ll continue to keep us updated on your progress. With that, thank you very much for taking the time today.
2025-12-13 10:244mo ago
2025-12-13 04:264mo ago
GPIX Vs. JEPI: Why Goldman's ETF Is The Superior Income Choice
SummaryThis article reveals the main reasons why GPIX is in my portfolio, not JEPI.I favor GPIX for its profitability, tax advantages, and growth participation, while noting JEPI's appeal for conservative capital seeking stability.There are three main criteria that make these ETFs distinct from one another.The decrease in the probability of a U.S. economic recession increases the chances of a continued bull trend, where GPIX is more profitable. monsitj/iStock via Getty Images
Investment thesis The Goldman Sachs S&P 500 Premium Income ETF (GPIX) and JPMorgan Equity Premium Income ETF (JEPI) funds are among the hottest assets for investors looking for steady passive income. Because their
Analyst’s Disclosure:I/we have a beneficial long position in the shares of GPIX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SummaryLinde's EPS growth is underpinned by management actions, pricing power, cost control, and productivity, supporting a credible path to low-to-mid-teens EPS growth.Emerging growth vectors in space and electronics, alongside AI-driven productivity, provide additional upside to organic volume and margin expansion.Following the recent sell-off, shares offer 20% upside over 12 months plus a 1.5% dividend yield, reinforcing our Buy view on this high-quality, long-duration compounder. Lukassek/iStock Editorial via Getty Images
Following our recent update on Air Products and Chemicals, we return to Linde plc (LIN). In our previous note, we upgraded Linde to overweight, as the key drivers behind our neutral view
Analyst’s Disclosure:I/we have a beneficial long position in the shares of LIN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Quick Insights
Recommended For You
2025-12-13 10:244mo ago
2025-12-13 04:324mo ago
Why Is The Trade Desk Stock Crashing, and Is It a Buying Opportunity for 2026?
The sell-off in The Trade Desk stock has it selling for relatively cheap valuations.
The Trade Desk (TTD 1.04%) faces increasing competition, which is concerning to investors.
*Stock prices used were the afternoon prices of Dec. 10, 2025. The video was published on Dec. 12, 2025.
Parkev Tatevosian, CFA has positions in The Trade Desk. The Motley Fool has positions in and recommends The Trade Desk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
SummaryEli Lilly is positioned for a secular growth trajectory, leveraging its duopoly in diabetes and obesity therapies while investing heavily in pipeline diversification.LLY faces intensifying competition and looming patent expirations, but is proactively expanding into oral, triple-agonist, and novel biologic modalities to sustain long-term revenue.Valuation risk is high in the near term, yet the robust pipeline support a buy rating for long-term investors.LLY’s Catalyze360 platform and strategic bolt-on acquisitions signal a shift toward diversified innovation, aiming to offset future revenue declines as exclusivity wanes. JHVEPhoto/iStock Editorial via Getty Images
Introduction Eli Lilly (LLY) has generated their Keytruda/Humira moment. A generation-defining medicine that in fact owns a duopoly, for the time being, with Novo Nordisk (NVO). Cash flows for the next
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Buying these high-yield dividend stocks should be an easy decision.
You don't have to wait until the New Year to celebrate. At least, that's the case if you're an income investor. There are plenty of great dividend stocks worth cheering about.
One problem, though, is that selecting which dividend stocks to buy can be difficult. However, I think some stocks make the decision-making process easy. Here are three no-brainer dividend stocks to buy right now.
Image source: Getty Images.
1. Evergy
If you don't live in Kansas or Missouri, you might not be familiar with Evergy (EVRG +0.59%). However, if you do live in either of those states, the company is a household name. Evergy provides energy to around 1.7 million customers in Kansas and Missouri through its subsidiaries Evergy Kansas Central, Evergy Metro, and Evergy Missouri West.
I think this stock should be a household name for income investors nationwide. Evergy's forward dividend yield is 3.8%. The energy provider has increased its dividend for 22 consecutive years, including a 4% increase announced last month.
Today's Change
(
0.59
%) $
0.43
Current Price
$
73.80
Like many utility stocks, Evergy has delivered solid gains in 2025. Evergy's performance is especially impressive considering the weather headwinds the company faced in the second and third quarters, with what CEO David Campbell called "cooler than normal summer weather."
Over the long term, though, Evergy's prospects remain strong. Both Kansas and Missouri offer tax incentives for data centers, making the states attractive to tech companies. Relative to its modest size, Evergy's backlog of large customers requiring power is one of the largest in the U.S.
2. Prudential Financial
Prudential Financial (PRU 0.08%) has one of the most recognizable slogans of the last few decades: "Get a piece of the rock." The financial services company currently has approximately $1.6 trillion in assets under management and operates in the U.S., Asia, Europe, and Latin America.
The company's dividend has been rock-solid. Prudential has increased its dividend for 17 consecutive years and counting. Its forward dividend yield is 4.7%. The financial services giant also has a manageable dividend payout ratio of 73%.
Today's Change
(
-0.08
%) $
-0.09
Current Price
$
116.96
Granted, Prudential's stock performance has been underwhelming. Shares remain down year to date while the S&P 500 (^GSPC 1.07%) has soared by 17%. However, the overall market is priced at a premium, but Prudential isn't. Its forward price-to-earnings ratio is a low 7.8.
Even better, the picture could be improving for the company. Prudential reported record-high adjusted earnings per share in the third quarter of 2025, with growth in every business. Management is focused on improving margins and offering more products and services to retirees, a tremendous growth opportunity.
3. Realty Income
Realty Income (O +0.87%) ranks as the sixth-largest global real estate investment trust (REIT). It owns 15,542 properties in nine countries valued at $61 billion. The REIT has 1,647 tenants representing 92 industries, including familiar names such as 7-Eleven (owned by Seven & I Holdings (SVNDY +1.24%)), Dollar General (DG +0.40%), Walgreens, Wynn Resorts (WYNN 0.95%), and FedEx (FDX 0.15%).
You won't find many dividend programs as good as Realty Income's. The REIT pays its dividends monthly and has even registered the trademark of "The Monthly Dividend Company." Realty Income has increased its dividend for 30 consecutive years and 113 consecutive quarters. Its forward dividend yield is a juicy 5.7%.
Today's Change
(
0.87
%) $
0.50
Current Price
$
57.72
Sure, Realty Income's stock hasn't delivered awe-inspiring gains this year. However, its total return isn't too shabby.
Most importantly, Realty Income offers investors both stability and solid growth prospects. Since listing on the New York Stock Exchange in 1994, its beta is only 0.5, indicating low volatility. The REIT's total addressable market is $14 trillion. Around $8.5 trillion of that total is in Europe, where Realty Income doesn't face significant competition.
2025-12-13 10:244mo ago
2025-12-13 04:564mo ago
Enterprise Products: High-Conviction Play Going Into 2026
Analyst’s Disclosure:I/we have a beneficial long position in the shares of EPD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-13 10:244mo ago
2025-12-13 05:004mo ago
A tale of two bids: What Netflix and Paramount's pursuit of WBD means for Hollywood, viewers and investors
Like a thrilling corporate drama, the battle for Warner Bros Discovery acquired a sensational new subplot last week when, not willing to let go, Paramount Skydance made a comeback with a $108.4 billion all-cash hostile bid for the studio powerhouse, just days after WBD had sealed a deal with Netflix.
Paramount went straight to investors on Monday with a $30-a-share tender for all of WBD.
Netflix, whose offer arrived first, had valued the company’s studio and streaming assets at $27.75 a share through a mix of cash and stock.
Netflix has proposed a cash-and-stock acquisition of WBD’s studios and streaming businesses, excluding its cable assets, while Paramount wants the entire company—from Warner Bros studios and streaming to CNN and Discovery.
The offers arrive at a moment when media consolidation is reshaping the competitive landscape, and the outcome is expected to influence everything from streaming prices and theatrical releases to employment across Hollywood.
While both companies argue their bids are superior, the implications vary significantly depending on the chosen buyer.
Investors, regulators, Hollywood unions and consumer advocates are weighing not only deal value but also the long-term impact on the industry.
How the offers differ in structure and strategic intent
Copy link to section
Netflix’s proposal, valued at $27.75 a share, focuses on acquiring only the crown jewels of Warner Bros: its iconic studios, HBO and HBO Max, and the associated streaming businesses.
The cable channels—including CNN, Cartoon Network and Discovery—would be spun into a separate company. Investors would receive $23.25 in cash and $4.50 in Netflix stock.
Paramount’s bid, by contrast, is simpler but more sweeping.
It offers WBD shareholders $30 in cash per share for the entire company.
David Ellison, Paramount’s chief executive, has argued that acquiring all of WBD would dramatically scale Paramount’s streaming ambitions and give regulators a cleaner, more straightforward transaction to assess.
Analysts note that the “total value” of both offers is close once adjustments are made for what Netflix is choosing to leave out.
Yet Paramount’s all-cash structure is attractive to investors seeking certainty amid market volatility.
Many now expect Paramount to increase its offer, after internal advisers signalled that the $30 bid was not “best and final.”
Impact on jobs: consolidation likely to bring steep cuts
Copy link to section
Both potential owners claim their deal would be more job-preserving than the alternative, but consolidation on this scale almost always results in redundancies.
The existing merger that created WBD already led to several thousand layoffs, and another round—whether under Netflix or Paramount—appears inevitable.
Paramount executives have said they expect at least $6 billion in savings over three years.
Analysts estimate this would translate into as many as 6,000 job cuts across overlapping film, TV and corporate functions.
Paramount also owns its own studio lot, cable channels and news operations, creating additional areas of duplication.
Netflix’s integration, analysts say, would be less severe in the near term.
Without a legacy studio complex of its own, Netflix would rely heavily on WBD’s existing infrastructure and production teams, reducing immediate pressure for cuts.
However, Netflix has stated that it seeks $2–3 billion in savings, primarily through procurement and distribution efficiencies.
Over time, consolidation of production units and back-office systems could shrink headcount.
Hollywood unions have already called for regulators to block Netflix’s offer on the grounds that it could centralise too much power in a company viewed as hostile to theatrical releases.
However, they acknowledge that a Paramount takeover would also lead to job losses—just potentially in different places.
What the Netflix offer implies for viewers
Copy link to section
A Netflix takeover would unite the world’s largest streaming service with HBO’s prestige offerings and Warner Bros’ deep film library.
For viewers, this raises three major questions: how streaming packages may change, whether theatrical windows will shrink, and how pricing will evolve.
Netflix has told its subscribers that nothing will change immediately and that HBO Max will continue as a separate service for the foreseeable future.
But industry analysts believe bundling is inevitable. Integrating HBO titles into Netflix’s global distribution engine would give Netflix an unprecedented programming footprint.
Co-CEO Greg Peters has suggested the companies could eventually introduce mixed subscription plans, bringing HBO originals under Netflix’s pricing tiers.
The larger concern for cinemas is whether Netflix would eventually shorten theatrical windows for major Warner Bros releases.
The company has historically favoured quick streaming debuts and limited theatrical runs.
While it has committed to maintaining Warner’s established theatrical contracts through 2029, long-term incentives may shift.
For consumers, consolidation typically leads to higher prices.
Experts expect subscription fees for any Netflix-HBO Max bundle to increase within 12–18 months of a deal closing.
What the Paramount offer implies for viewers
Copy link to section
Paramount has argued that combining its studio with Warner Bros would expand theatrical outputs, not shrink them.
Paramount sits at an “existential crossroads” right now because buying Warner Discovery would be crucial to helping the company scale its direct-to-consumer streaming business, MoffettNathanson analyst Robert Fishman wrote Monday in a research note.
Ellison has pledged to release at least 30 films a year—significantly more than either studio currently produces independently.
Paramount owns CBS News and dozens of cable channels.
A combined entity could reshape the US news and entertainment landscape, creating potential synergies but also raising fears of reduced diversity in content.
Bundling CBS, Paramount+ and HBO Max into a single subscription could create one of the industry’s largest entertainment packages, almost certainly at a higher price point.
The merger would also give Paramount a broad content library similar in scale to Disney’s.
Analysts believe the combined company would eventually consolidate its streaming offerings under a single umbrella, likely retiring the Paramount+ brand and re-centring the business around a unified Warner-Paramount service.
How regulators may view both offers
Copy link to section
Both deals face intense regulatory scrutiny, though analysts differ on which one stands a better chance.
Netflix has 302 million paying subscribers, compared with 128 million at WBD and 79 million at Paramount.
A tie-up between Netflix and WBD would significantly strengthen its lead as the world’s largest streaming platform, typically a major concern for regulators.
But if authorities treat YouTube and TikTok as part of the competitive landscape, Netflix’s market share appears far less dominant.
Paramount believes it has an advantage because it is much smaller.
But the political dimension complicates the picture.
Trump has long been critical of CNN, frequently branding it “Fake News,” and some analysts suggest he may prefer to see the network folded into Paramount’s portfolio.
Paramount already owns CBS News, which recently appointed Bari Weiss — a vocal critic of progressive cultural trends — as editor-in-chief.
From a regulatory standpoint, a Paramount bid would draw scrutiny over the merger of two major Hollywood studios.
But beyond the economics, political considerations loom large.
Trump said on Sunday that he “would be involved” in determining who ultimately acquires WBD, indicating he could influence the process through the Justice Department’s antitrust authority.
On the surface, Paramount may appear to have an edge: David Ellison is the son of Oracle founder Larry Ellison, a close Trump ally, and Jared Kushner, the president’s son-in-law, is among the financial backers of the Paramount offer.
Polymarket odds suggest a near-tie, with a 42% chance each that Netflix or Paramount will succeed before June 2027.
Ball in WBD’s investors’ court as they expect Paramount to sweeten the bid
Copy link to section
WBD shares bounced back 9% on Monday after Paramount unveiled its hostile bid, reversing the 9.8% drop recorded on Friday when Netflix announced its agreement with the studio.
Paramount chief executive David Ellison spent Tuesday meeting Warner investors in New York, urging them to press the company’s management and board to favour his bid over Netflix’s, according to people familiar with the discussions.
Several attendees left the meetings believing a higher bid from Paramount was likely, The Wall Street Journal reported.
Warner’s stock climbed roughly 4% across Tuesday and Wednesday as the meetings unfolded, trading close to $30 a share — just shy of both offer values.
That narrow gap suggests investors believe at least one bidder will return with an improved proposal, hedge-fund managers said.
If investors doubted a deal would close, the stock would trade at a steeper discount, given the lengthy timeline and regulatory risk involved.
Instead, the pricing indicates expectations for a swift outcome.
Shareholders broadly anticipate that Paramount will raise its offer.
A regulatory filing on Monday offered the clearest hint yet that Paramount is prepared to pay more.
In it, Blair Effron of Centerview, advising Paramount, texted Evercore’s Roger Altman — who is advising WBD — to underline that Paramount’s previous proposal “did not include ‘best and final’.”
Effron reached out after WBD chief David Zaslav did not respond to Ellison’s December 4 message expressing willingness to go further to secure a deal.
If Paramount ultimately raises its offer, WBD could argue that agreeing to Netflix’s deal helped draw a richer bid from a rival, potentially supporting its decision-making, analysts said.
Warner Bros. Discovery shares have surged almost 40% — from just over $21 before the offers emerged to just under $29.
Paramount’s $30-a-share bid for the entire company, including the cable networks, has pushed the stock above the value implied by Netflix’s proposal.